LEANDRA BERRIOS: Open Payments
NPI 1982154159 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 21 payments from 9 companies in 2025. Trend: 2023 $1,195 · 2024 $635 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $180 |
| AstraZeneca Pharmaceuticals LP | 2 | $153 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Astellas Pharma US Inc | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $20 |
| Incyte Corporation | 1 | $17 |
| BeOne Medicines USA, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: JEMPERLI, Enhertu, DATROWAY, Veozah, DARZALEX, APTIMA, NIKTIMVO, TEVIMBRA.
Industry payments across FL — which companies pay providers there.
